Advertisement

Topics

FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

18:50 EDT 25 Jun 2018 | News-Medical.net

The U.S. Food and Drug Administration today approved Epidiolex (cannabidiol) oral solution for the treatment of seizures associated with two rare and severe forms of epilepsy, Lennox-Gastaut syndrome and Dravet syndrome, in patients two years of age and older.

Original Article: FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy

NEXT ARTICLE

More From BioPortfolio on "FDA approves new marijuana-based drug to treat rare and severe forms of epilepsy"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Neurology - Central Nervous System (CNS)
Alzheimer's Disease Anesthesia Anxiety Disorders Autism Bipolar Disorders Dementia Epilepsy Multiple Sclerosis (MS) Neurology Pain Parkinson's Disease Sleep Disorders Neurology is the branch of me...